367 related articles for article (PubMed ID: 30874910)
21. Dermatofibrosarcoma protuberans in children: an update on the diagnosis and treatment.
Kornik RI; Muchard LK; Teng JM
Pediatr Dermatol; 2012; 29(6):707-13. PubMed ID: 22780227
[TBL] [Abstract][Full Text] [Related]
22. Giant Dermatofibrosarcoma Protuberans With Bilateral Orbital Involvement.
Liou V; Chisholm SA; Logunova V; Havlik R; Esmaili N
Ophthalmic Plast Reconstr Surg; 2019; 35(2):e36-e39. PubMed ID: 30730435
[TBL] [Abstract][Full Text] [Related]
23. Dermatofibrosarcoma Protuberans.
Allen A; Ahn C; Sangüeza OP
Dermatol Clin; 2019 Oct; 37(4):483-488. PubMed ID: 31466588
[TBL] [Abstract][Full Text] [Related]
24. Application of COL1A1-PDGFB fusion gene detection by fluorescence in situ hybridization in biopsy tissue of dermatofibrosarcoma protuberans.
Zhang Z; Chen H; Chen M; He X; Wang Y; Zhang H
J Dermatol; 2017 Jul; 44(7):798-802. PubMed ID: 28150334
[TBL] [Abstract][Full Text] [Related]
25. Remission with Imatinib mesylate treatment in a patient with initially unresectable dermatofibrosarcoma protuberans--a case report.
Lemm D; Muegge LO; Hoeffken K; Aklan T; Mentzel T; Thorwarth M; Schultze-Mosgau S
Oral Maxillofac Surg; 2008 Dec; 12(4):209-13. PubMed ID: 18751744
[TBL] [Abstract][Full Text] [Related]
26. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
[TBL] [Abstract][Full Text] [Related]
27. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract][Full Text] [Related]
28. Dermatofibrosarcoma protuberans: recent clinical progress.
McArthur G
Ann Surg Oncol; 2007 Oct; 14(10):2876-86. PubMed ID: 17647063
[TBL] [Abstract][Full Text] [Related]
29. Clinical Features and Treatment of Dermatofibrosarcoma Protuberans Affecting the Vulva: A Literature Review.
Nguyen AH; Detty SQ; Gonzaga MI; Huerter C
Dermatol Surg; 2017 Jun; 43(6):771-774. PubMed ID: 28323651
[TBL] [Abstract][Full Text] [Related]
30. Targeted therapy for dermatofibrosarcoma protuberans.
Abrams TA; Schuetze SM
Curr Oncol Rep; 2006 Jul; 8(4):291-6. PubMed ID: 17254529
[TBL] [Abstract][Full Text] [Related]
31. PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.
Jahanseir K; Xing D; Greipp PT; Sukov WR; Keeney GL; Howitt BE; Schoolmeester JK
Int J Gynecol Pathol; 2018 Nov; 37(6):537-546. PubMed ID: 29140881
[TBL] [Abstract][Full Text] [Related]
32. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
Mentzel T; Schärer L; Kazakov DV; Michal M
Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
[TBL] [Abstract][Full Text] [Related]
33. [New molecular approaches in dermatofibrosarcoma protuberans].
Kaya G
Rev Med Suisse; 2009 Jul; 5(211):1519-24. PubMed ID: 19694363
[TBL] [Abstract][Full Text] [Related]
34. Review of dermatofibrosarcoma protuberans.
Lim SX; Ramaiya A; Levell NJ; Venables ZC
Clin Exp Dermatol; 2023 Mar; 48(4):297-302. PubMed ID: 36630365
[TBL] [Abstract][Full Text] [Related]
35. Molecularly targeted treatment for dermatofibrosarcoma protuberans.
McArthur G
Semin Oncol; 2004 Apr; 31(2 Suppl 6):30-6. PubMed ID: 15176002
[TBL] [Abstract][Full Text] [Related]
36. [Dermatofibrosarcoma protuberans : clinico-pathological aspects and management].
Grizzetti L; Gaide O; Kuonen F
Rev Med Suisse; 2020 Apr; 16(688):640-645. PubMed ID: 32239838
[TBL] [Abstract][Full Text] [Related]
37. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.
Terrier-Lacombe MJ; Guillou L; Maire G; Terrier P; Vince DR; de Saint Aubain Somerhausen N; Collin F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2003 Jan; 27(1):27-39. PubMed ID: 12502925
[TBL] [Abstract][Full Text] [Related]
38. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.
Wang WL; Patel KU; Coleman NM; Smith-Zagone MJ; Ivan D; Reed JA; López-Terrada D; Lazar AJ; Prieto VG
Am J Dermatopathol; 2010 Apr; 32(2):149-53. PubMed ID: 19940748
[TBL] [Abstract][Full Text] [Related]
39. PDGFB RNA in situ hybridization for the diagnosis of dermatofibrosarcoma protuberans.
Cloutier JM; Allard G; Bean GR; Hornick JL; Charville GW
Mod Pathol; 2021 Aug; 34(8):1521-1529. PubMed ID: 33762682
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans.
Karanian M; Pérot G; Coindre JM; Chibon F; Pedeutour F; Neuville A
Mod Pathol; 2015 Feb; 28(2):230-7. PubMed ID: 25081750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]